Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1Motor Activity 1Inflammation 1Feeding Behavior 1Digestive System Neoplasms 1Colorectal Neoplasms 1Cachexia 1Breast Neoplasms 1Breast Diseases 1

Interventions

Megestrol Acetate 9Exercise 6Standard of Care 4Blood Specimen Collection 4Olanzapine 3Ibuprofen 3dermcidin 2anamorelin 2Resistance Training 2Physical Therapy Modalities 2Nutrition Assessment 2Mirtazapine 2Melatonin 2Infliximab 2Enteral Nutrition 2Dietary Supplements 2Diet Therapy 2Cyproheptadine 2testosterone enanthate 1telotristat ethyl 1remune 1ostarine 1olanzapine-fluoxetine combination 1nabiximols 1nabilone 1irinotecan sucrosofate 1fucoidan 1clazakizumab 1bermekimab 1alkaloid GB18 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cachexia × Body Height × Clear all
NCT03172403 2022-08-25

MYOCAC

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Terminated
3 enrolled
Gastrointestinal

Cachexia, Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡